Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Option Grant

22 Aug 2023 08:00

RNS Number : 9833J
finnCap Group PLC
22 August 2023
 

22 August 2023

finnCap Group plc

("finnCap", "the Company" or the "Group")

Option Grant

finnCap today announces completion of the grant of options under the finnCap Group plc Company Share Option Plan (the "Plan") to John Farrugia, CEO. 

Due to various corporate transactions and closed periods, it has not previously been possible for the Company to complete the issue of these incentive awards to Mr Farrugia as intended upon his appointment as CEO on 1 September 2022 and as described in the Group's Remuneration Committee report included in the Company's Annual Report and Accounts for the year-ended 31 March 2022.

The grant comprises a retention option over 2,000,000 shares with an exercise price of 1p per share, and an incentive option over 5,000,000 shares with an exercise price of 15p per share (together the "Options"). Due to various corporate transactions and closed periods since his appointment as CEO it has not been possible to formalise the grant until now. In the ordinary course, the Options will vest and become exercisable on 25 July 2025, subject to continuing employment. For the avoidance of doubt, vesting will not accelerate on completion of the recommended all-share merger between finnCap and Cenkos Securities plc.

The Options are also subject to malus and clawback for a period of two years following vesting. The Options will lapse, to the extent not exercised, on the day immediately preceding the tenth anniversary of the date of grant.

Following these awards, John Farrugia continues to have a beneficial interest over 1,927,669 Ordinary Shares (as set out in the Company's Opening Position Disclosure dated 4 April 2023 under Rule 8 of the Takeover Code), representing approximately 1.06% of the current total voting rights of the Company, and has options over Ordinary Shares in the Company as set out below:

Name of Scheme or Plan

Number of ordinary shares under options/awards

Grant Date

Vesting date

Normal lapse date

Exercise price (per share)

finnCap Group plc Company Share Option Plan

305,045

05/12/2018

05/12/2020

05/12/2023

£0.28

152,523

05/12/2018

05/12/2021

05/12/2023

£0.28

152,522

05/12/2018

05/12/2022

05/12/2023

£0.28

425,000

01/04/2020

09/07/2024

09/07/2027

£0.175

666,667

18/08/2020

01/04/2022

01/04/2025

£0.01

666,667

18/08/2020

01/04/2023

01/04/2026

£0.01

2,000,000

22/08/2023

25/07/2025

22/08/2033

£0.01

5,000,000

22/08/2023

25/07/2025

22/08/2033

£0.15

finnCap Group plc Enterprise Management Share Option Plan

775,000

01/04/2020

09/07/20241

09/07/2027

£0.175

1 Subject to the satisfaction of performance conditions

The Company's Ordinary Shares referred to above are finnCap Group plc ordinary shares of 1 penny each and the total number of shares in issue is 181,094,844.

Further details on this are included in the notification below, made in accordance with the requirements of the UK Market Abuse Regulation.

Contacts

 

finnCap Group plc Tel: +44 (0) 20 7220 0500

Robert Lister, Chairman investor.relations@finncap.com

Richard Snow, Chief Financial Officer

 

Grant Thornton (Nominated Adviser)  Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison/Samuel Littler

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

John Farrugia

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

finnCap Group plc

b)

 

LEI

 

 

213800DLRUJW6JVNS533

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

GB00BGKPX309

b)

 

Nature of the transaction

 

 

(1) Grant of options over ordinary shares under the finnCap Group plc Company Share Option Plan at an exercise price of 1p per share

 

(2) Grant of options over ordinary shares under the finnCap Group plc Company Share Option plan at an exercise price of 15p per share

 

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

(1) £0.01

(1) 2,000,000

(2) £0.15

(2) 5,000,000

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

22 August 2023

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKPFAASDEFA
Date   Source Headline
1st Jun 20217:00 amRNSBlock Admission Return and Total Voting Rights
13th May 20217:00 amRNSDirector Dealing, Option Exercise & TVR
30th Apr 20217:00 amRNSTotal Voting Rights
8th Apr 202111:06 amRNSSecond Price Monitoring Extn
8th Apr 202111:00 amRNSPrice Monitoring Extension
7th Apr 20217:00 amRNSFY21 Unaudited Total Income - Strong end to FY21
1st Apr 20217:00 amRNSTotal Voting Rights
5th Mar 20219:16 amRNSDirectors’ Dealings
3rd Mar 20214:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:35 pmRNSPrice Monitoring Extension
3rd Mar 20211:55 pmRNSFY21 Trading Update
1st Mar 20217:00 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSAppointment of Broker
1st Feb 20217:00 amRNSTotal Voting Rights
4th Jan 20217:00 amRNSTotal Voting Rights
4th Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20207:00 amRNSBlock Admission Return and Total Voting Rights
18th Nov 202010:54 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSBoard Changes
18th Nov 20207:00 amRNSInterim Results and Interim Dividend
30th Oct 20207:00 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSTotal Voting Rights
21st Sep 20202:12 pmRNSResult of AGM
21st Sep 20207:00 amRNSAGM Trading Statement
3rd Sep 20209:12 amRNSOption Exercise - Director/PDMR Shareholding
1st Sep 202011:40 amRNSTotal Voting Rights- Replacement
1st Sep 20207:00 amRNSTotal Voting Rights
17th Aug 20207:00 amRNSAdditional Block Admission of Shares
13th Aug 202012:30 pmRNSOption Grant
31st Jul 202010:18 amRNSAnnual Report and Annual General Meeting Notice
31st Jul 20207:00 amRNSTotal Voting Rights
7th Jul 20207:00 amRNSPreliminary results - year ended 31 March 2020
1st Jul 20207:00 amRNSTotal Voting Rights
16th Jun 20208:56 amRNSChange of Registered Office
1st Jun 20207:00 amRNSBlock Admission Return and Total Voting Rights
26th May 202010:20 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSProperty Financing
20th May 20207:00 amRNSDirectorate Changes
6th May 20209:54 amRNSDirector’s Dealing and Concert Party Update
1st May 20207:00 amRNSTotal Voting Rights
2nd Apr 20207:00 amRNSOption Surrenders and Grants
1st Apr 20203:11 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSTrading Update
12th Mar 20201:44 pmRNSHolding(s) in Company
4th Mar 20207:00 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSTrading Update
14th Feb 20207:00 amRNSNew Director Appointment
4th Feb 20207:00 amRNSTotal Voting Rights
23rd Jan 20203:32 pmRNSDirector/PDMR Shareholding
17th Jan 20202:52 pmRNSSigning of new lease to consolidate premises

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.